Results 41 to 50 of about 822 (147)

Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial. [PDF]

open access: yesBJU Int
Lee SW   +20 more
europepmc   +1 more source

Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. [PDF]

open access: yesInt J Urol
Inamura S   +9 more
europepmc   +1 more source

Steroid diversification by multicomponent reactions. [PDF]

open access: yesBeilstein J Org Chem, 2019
Reguera L   +3 more
europepmc   +1 more source

Anticancer Activities of Natural and Synthetic Steroids: A Review. [PDF]

open access: yesACS Omega
Mendoza Lara DF   +4 more
europepmc   +1 more source

Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. [PDF]

open access: yesCancer
Zheng R   +7 more
europepmc   +1 more source

SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis. [PDF]

open access: yesPharmaceuticals (Basel), 2020
Appetecchia F   +4 more
europepmc   +1 more source

Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms. [PDF]

open access: yesBr J Clin Pharmacol, 2021
D'Agate S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy